BURLINGTON, Mass., June 4, 2014 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) (the “Company”), a provider of peripheral vascular devices and implants, today announced the closing of its previously announced underwritten public offering of 1,644,500 shares of its common stock at a price to the public of $7.00 per share. The shares include 214,500 shares of common stock sold pursuant to the over-allotment option granted by LeMaitre Vascular to the underwriters, which option was exercised in full.
Help employers find you! Check out all the jobs and post your resume.